相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
Zehra Kaymakcalan et al.
CLINICAL IMMUNOLOGY (2009)
Differences in binding and effector functions between classes of TNF antagonists
Taruna Arora et al.
CYTOKINE (2009)
Influence of reverse signaling via membrane TNF-α on cytotoxicity of NK92 cells
Mingxia Yu et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2009)
Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans
Heiko Bruns et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Lipid rafts uncouple surface expression of transmembrane TNF-alpha from its cytotoxicity associated with ICAM-1 clustering in Raji cells
Shu Zhang et al.
MOLECULAR IMMUNOLOGY (2009)
Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor α-expressing cells
Hiroki Mitoma et al.
ARTHRITIS AND RHEUMATISM (2008)
An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection
Cindy Allenbach et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
Robert S. Walls
LANCET INFECTIOUS DISEASES (2008)
A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases
Manuel Ramos-Casals et al.
MEDICINE (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Differential requirements by CD4+ and CD8+ T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth
Siobhan C. Cowley et al.
JOURNAL OF IMMUNOLOGY (2007)
Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor at agents
Andrew Nesbitt et al.
INFLAMMATORY BOWEL DISEASES (2007)
Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells
Manuela Rossol et al.
JOURNAL OF IMMUNOLOGY (2007)
Binding characteristics of tumor necrosis factor receptor-Fc fusion proteins vs anti-tumor necrosis factor mAbs
Tadahiko Kohno et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2007)
Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk
Jun Xu et al.
BLOOD (2007)
A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis
Takahiko Horiuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Drug Insight: different mechanisms of action of tumor necrosis factor antagonists - passive-aggressive behavior?
William F. C. Rigby
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Molecular aspects of human FcγR interactions with IgG:: Functional and therapeutic consequences
Sophie Siberil et al.
IMMUNOLOGY LETTERS (2006)
The cytoplasmic domain of Fas ligand costimulates TCR signals
Mingyi Sun et al.
JOURNAL OF IMMUNOLOGY (2006)
SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production
Elena Friedmann et al.
NATURE CELL BIOLOGY (2006)
A γ-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2b
Regina Fluhrer et al.
NATURE CELL BIOLOGY (2006)
Membrane tumor necrosis factor confers partial protection to Listeria infection
D Torres et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Membrane TNF confers protection to acute mycobacterial infection
C Fremond et al.
RESPIRATORY RESEARCH (2005)
Kupffer cell-expressed membrane-bound TNF mediates melphalan hepatotoxicity via activation of both TNF receptors
M Kresse et al.
JOURNAL OF IMMUNOLOGY (2005)
Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells
NK Vudattu et al.
IMMUNOLOGY (2005)
Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection
BM Saunders et al.
JOURNAL OF IMMUNOLOGY (2005)
Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-Guerin and Mycobacterium tuberculosis infections
ML Olleros et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Biological activities of reverse signal transduction through CD137 ligand
H Schwarz
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis
A Constantin et al.
ARTHRITIS AND RHEUMATISM (2004)
Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system
G Eissner et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Function and regulation of tumor necrosis factor receptor type 2
I Carpentier et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Tumour necrosis factor-α receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab
M Pierik et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs
Q Wang et al.
TISSUE ANTIGENS (2004)
Granulomatous infectious diseases associated with tumor necrosis factor antagonists
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Targeted overexpression of transmembrane tumor necrosis factor provokes a concentric cardiac hypertrophic phenotype
ZI Dibbs et al.
CIRCULATION (2003)
Stress-activated cytokines and the heart: From adaptation to maladaptation
DL Mann
ANNUAL REVIEW OF PHYSIOLOGY (2003)
IFN-γ-induced apoptosis and microbicidal activity in monocytes harboring the intracellular bacterium Coxiella burnetii require membrane TNF and homotypic cell adherence
J Dellacasagrande et al.
JOURNAL OF IMMUNOLOGY (2002)
Guanidinoethyl sulphonate is a glycine receptor antagonist in striatum
OA Sergeeva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Binding and functional comparisons of two types of tumor necrosis factor antagonists
B Scallon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Exclusive action of transmembrane TNFα in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance
HY Xu et al.
ENDOCRINOLOGY (2002)
Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-α
ML Olleros et al.
JOURNAL OF IMMUNOLOGY (2002)
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease
T ten Hove et al.
GUT (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Transmembrane TNF (pro-TNF) is palmitoylated
T Utsumi et al.
FEBS LETTERS (2001)
Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4(+) T cells
S Harashima et al.
JOURNAL OF IMMUNOLOGY (2001)
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
FKM Chan et al.
SCIENCE (2000)
Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages
G Eissner et al.
JOURNAL OF IMMUNOLOGY (2000)
Cytokine modulated cell-membrane bound tumour necrosis factor expression is associated with enhanced monocyte-mediated killing of human leukaemic targets
MA Williams et al.
LEUKEMIA RESEARCH (2000)
Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome
L Armstrong et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
分享论文
